July 10, 2009 – New British Heart Foundation (BHF) research(1) revealed today suggests for the first time that ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
July 6, 2009 – Sanofi-aventis said last week the FDA approved its Multaq (dronedarone) 400 mg tablets for use in ...
July 1, 2009 – Cardioxyl Pharmaceuticals Inc. announced today the initiation of a phase I/IIa dose-escalation ...
June 29, 2009 – Cordex Pharma said today it successfully completed the production of the ATPace clinical trial ...
June 15, 2009 - Mayo Clinic received $48 million in grants from the National Heart, Lung and Blood Institute ...
June 09, 2009 – Talecris Biotherapeutics Inc., said today it was granted orphan drug designation by the FDA for ...
June 2, 2009 - Cordex Pharma Inc. said today the FDA cleared the design of pivotal, phase 2b/3 clinical trials ...
June 1, 2009 - Results and updates from eight studies were presented during a late-breaking trials session at ...
May 26, 2009 - United Therapeutics Corp. said today the FDA approved ADCIRCA (tadalafil) tablets for oral ...
April 10, 2009 - Merck & Co., Inc. and Cardiome Pharma Corp. are collaborating on the development and ...
April 9, 2009 - According to research presented last week at ACC, patients with the CYP2C19*2 genotype had more ...
April 8, 2009 - The CUPID clinical trial demonstrated acceptable safety and produced quantitative evidence of ...
April 7, 2009 - Lantheus Medical Imaging Inc. has acquired the U.S., Canadian and Australian rights to MS-325 ...
April 2, 2009 - New findings from a landmark investigational study demonstrated that, for patients with atrial ...
April 1, 2009 - On March 30, the Heart Hospital of Austin, TX became the first hospital in the world to treat a ...
July 10, 2009